View Older Stories View More Recent Stories

Oct 28, 2014 12:06PM Streetinsider.com's Hot Lunchtime Reads 10/28: (GT) (NE) (COH) (CRIS)
Oct 28, 2014 11:47AM Curis' (CRIS) CUDC-907 IP Protection 'Strong' Following Latest Allowance - Roth Capital
Oct 28, 2014 10:48AM Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock
Oct 27, 2014 01:57PM Roth Capital 'Impressed' with Ligand's (LGND) Q3 Results; Affirms at 'Buy'
Oct 27, 2014 09:38AM Roth Affirms Cytokinetics (CYTK) at 'Buy'; Latest COSMIC-HF Enrollment Data is Encouraging
Oct 27, 2014 07:29AM Stemline's (STML) Valuation is Compelling Heading into 'Data-Rich' 2015 - Roth Capital
Oct 24, 2014 11:15AM Ligand's (LGND) Duavee Will be Significant N-T Revenue Driver; CHMP Opinion is Encouraging - Roth
Oct 24, 2014 10:54AM Roth 'Encouraged' by Verastem's (VSTM) VS-6063 Effect on Biomarkers of CSCs
Oct 24, 2014 08:18AM Roth Capital Downgrades IGI Laboratories (IG) to Neutral
Oct 23, 2014 02:04PM Roth Capital 'Encouraged' by Cytori (CYTX) Receiving FDA Approval to Continue ATHENA
Oct 23, 2014 08:45AM Roth Capital Lifts PT on Ligand (LGND) 32% Ahead of Q3 Results
Oct 22, 2014 08:40AM Roth Affirms Ligand (LGND) at 'Buy' Following Strong Promacta Sales in Q3
Oct 20, 2014 12:53PM Unusual 11 Mid-Day Movers 10/20: (SCOK) (ESI) (SHOR) Higher; (IBIO) (NCR) (CPXX) Lower
Oct 20, 2014 09:59AM Roth Capital Maintains Cytokinetics (CYTK) at 'Buy' Following BENEFIT-ALS Update
Oct 17, 2014 03:31PM Roth Capital Remains Bullish on Hudson Technologies (HDSN); EPA Ruling 'Materially' Better than Expected
Oct 17, 2014 12:59PM Celator Pharmaceuticals (CPXX) Plans Common Stock, Warrants Offering
Oct 17, 2014 12:57PM Celator(R) Pharmaceuticals Announces Public Offering of Common Stock and Warrants to Purchase Common Stock
Oct 17, 2014 09:24AM Roth Boosts PT on Pharmacyclics (PCYC) to $188; Imbruvica Continues to Gain Traction
Oct 17, 2014 09:01AM Roth Capital Remains Positive on Regeneron (REGN); Latest Outcome Better Positions Eylea as Superior DME Treatment
Oct 16, 2014 02:22PM Roth Capital Positive on Curis (CRIS) Following Q3 Results from Roche/Erivedge
Oct 16, 2014 07:53AM Roth Capital Adds MEI Pharma (MEIP) to Focus List; Multiple Key Inflection Points Coming
Oct 15, 2014 06:54AM Roth Capital Downgrades Durata Therapeutics (DRTX) to Neutral
Oct 14, 2014 07:20AM Roth Capital Starts The Hackett Group (HCKT) at Buy
Oct 13, 2014 11:52AM New Pharmacyclics (PCYC) Collaboration Further Validates Imbruvica; Roth Boosts PT to $185
Oct 13, 2014 09:26AM Roth Sees Visibility in Cytokinetics' (CYTK) CK-107 Program Increasing Significantly Moving Forward
Oct 13, 2014 08:41AM NCE Status Won't Matter for Keryx Biopharma (KERX) - Roth Capital
Oct 10, 2014 04:11PM Cytori Therapeutics (CYTX) Closes on $13.5M in Financing
Oct 10, 2014 10:55AM Notable Analyst Rating Changes 10/10: (IPXL) (EA) (AON) Upgraded; (JCP) (GRPN) (BDSI) Downgraded
Oct 10, 2014 07:10AM Roth Capital Resumes XOMA, Ltd. (XOMA) at Buy
Oct 10, 2014 06:36AM Roth Capital Downgrades BioDelivery Sciences International (BDSI) to Neutral
Oct 9, 2014 05:30PM ARI Network Services, Inc. Announces the Appointment of Chad J. Cooper to Board of Directors
Oct 9, 2014 11:50AM Roth Positive on SolarCity's (SCTY) Loan Program; Sees Tail Risks Ebbing
Oct 9, 2014 06:36AM Roth Capital Upgrades Golden Minerals Company (AUMN) to Buy
Oct 8, 2014 11:33AM PlacementTracker Publishes Third Quarter 2014 PIPE Market League Tables
Oct 8, 2014 08:06AM Cytori Therapeutics (CYTX) Announces $13.5M Registered Direct Placement
Oct 7, 2014 12:23PM Roth Capital Cuts SodaStream International (SODA) to Neutral
Oct 7, 2014 10:56AM Notable Analyst Rating Changes 10/7: (IR) (ADHD) (AAPL) Upgraded; (SNSS) (DE) (CBSH) Downgraded
Oct 7, 2014 07:49AM Roth Keeps Regeneron (REGN) at 'Buy'; Another Eylea Approval is No Surprise
Oct 7, 2014 07:13AM Roth Capital Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Neutral
Oct 6, 2014 04:40PM Trina Solar (TSL) Closes 10.3M ADS, $115M Conv. Notes Offerings
Oct 6, 2014 09:43AM Roth Capital Affirms SolarCity (SCTY) at 'Buy'; Comments on Recent Meetings with Management
Oct 6, 2014 06:30AM Roth Capital Starts ContraFect Corp. (CFRX) at Buy; Market Missing Potential Impact of Bacteriophage Lysins
Oct 2, 2014 09:39AM Recent Moves by Curis (CRIS) May Increase Value of CUDC-907 - Roth Capital
Oct 1, 2014 09:11AM Trina Solar (TSL) Prices 10.3M ADS, $100M Conv. Notes Offering
Oct 1, 2014 07:50AM Lerge Commercial Exit by RGS Energy (RGSE) is 'Right Move' - Roth
Sep 30, 2014 10:44AM Latest Data for Regeneron's (REGN) Dupilumab Broadens Benefit Profile - Roth
Sep 29, 2014 01:49PM Roth Lowers Ests on Galena Biopharma (GALE) Following Special Committee Report
Sep 29, 2014 12:04PM Streetinsider.com's Hot Lunchtime Reads 9/29: (AAPL) (JACK) (BLRXX) (TSLA)
Sep 29, 2014 11:27AM Daiichi Sankyo, Ambit (AMBI) Deal is Positive for BioLineRx (BLRX) - Roth Capital
Sep 29, 2014 09:52AM Roth Maintains Keryx Biopharma (KERX) at Buy Following Initiation of Ferric Citrate Phase 2
View More Recent Stories View Older Stories